Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad
Cancer progression generates a chronic inflammatory state that dramatically influences hematopoiesis, originating different subsets of immune cells that can exert pro- or anti-tumor roles. Commitment towards one of these opposing phenotypes is driven by inflammatory and metabolic stimuli derived fro...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/16/5845 |
id |
doaj-abae675f90504ade884993d53ce51566 |
---|---|
record_format |
Article |
spelling |
doaj-abae675f90504ade884993d53ce515662020-11-25T03:36:21ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-08-01215845584510.3390/ijms21165845Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the CrossroadAugusto Bleve0Barbara Durante1Antonio Sica2Francesca Maria Consonni3Department of Pharmaceutical Sciences, Università del Piemonte Orientale “Amedeo Avogadro”, Largo Donegani, 2-28100 Novara, ItalyDepartment of Pharmaceutical Sciences, Università del Piemonte Orientale “Amedeo Avogadro”, Largo Donegani, 2-28100 Novara, ItalyDepartment of Pharmaceutical Sciences, Università del Piemonte Orientale “Amedeo Avogadro”, Largo Donegani, 2-28100 Novara, ItalyDepartment of Pharmaceutical Sciences, Università del Piemonte Orientale “Amedeo Avogadro”, Largo Donegani, 2-28100 Novara, ItalyCancer progression generates a chronic inflammatory state that dramatically influences hematopoiesis, originating different subsets of immune cells that can exert pro- or anti-tumor roles. Commitment towards one of these opposing phenotypes is driven by inflammatory and metabolic stimuli derived from the tumor-microenvironment (TME). Current immunotherapy protocols are based on the reprogramming of both specific and innate immune responses, in order to boost the intrinsic anti-tumoral activity of both compartments. Growing pre-clinical and clinical evidence highlights the key role of metabolism as a major influence on both immune and clinical responses of cancer patients. Indeed, nutrient competition (i.e., amino acids, glucose, fatty acids) between proliferating cancer cells and immune cells, together with inflammatory mediators, drastically affect the functionality of innate and adaptive immune cells, as well as their functional cross-talk. This review discusses new advances on the complex interplay between cancer-related inflammation, myeloid cell differentiation and lipid metabolism, highlighting the therapeutic potential of metabolic interventions as modulators of anticancer immune responses and catalysts of anticancer immunotherapy.https://www.mdpi.com/1422-0067/21/16/5845tumor-associated macrophages (TAMs)myeloid-derived suppressor cells (MDSCs)cancer immunotherapylipid metabolismobesityfatty acids |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Augusto Bleve Barbara Durante Antonio Sica Francesca Maria Consonni |
spellingShingle |
Augusto Bleve Barbara Durante Antonio Sica Francesca Maria Consonni Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad International Journal of Molecular Sciences tumor-associated macrophages (TAMs) myeloid-derived suppressor cells (MDSCs) cancer immunotherapy lipid metabolism obesity fatty acids |
author_facet |
Augusto Bleve Barbara Durante Antonio Sica Francesca Maria Consonni |
author_sort |
Augusto Bleve |
title |
Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad |
title_short |
Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad |
title_full |
Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad |
title_fullStr |
Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad |
title_full_unstemmed |
Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad |
title_sort |
lipid metabolism and cancer immunotherapy: immunosuppressive myeloid cells at the crossroad |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1661-6596 1422-0067 |
publishDate |
2020-08-01 |
description |
Cancer progression generates a chronic inflammatory state that dramatically influences hematopoiesis, originating different subsets of immune cells that can exert pro- or anti-tumor roles. Commitment towards one of these opposing phenotypes is driven by inflammatory and metabolic stimuli derived from the tumor-microenvironment (TME). Current immunotherapy protocols are based on the reprogramming of both specific and innate immune responses, in order to boost the intrinsic anti-tumoral activity of both compartments. Growing pre-clinical and clinical evidence highlights the key role of metabolism as a major influence on both immune and clinical responses of cancer patients. Indeed, nutrient competition (i.e., amino acids, glucose, fatty acids) between proliferating cancer cells and immune cells, together with inflammatory mediators, drastically affect the functionality of innate and adaptive immune cells, as well as their functional cross-talk. This review discusses new advances on the complex interplay between cancer-related inflammation, myeloid cell differentiation and lipid metabolism, highlighting the therapeutic potential of metabolic interventions as modulators of anticancer immune responses and catalysts of anticancer immunotherapy. |
topic |
tumor-associated macrophages (TAMs) myeloid-derived suppressor cells (MDSCs) cancer immunotherapy lipid metabolism obesity fatty acids |
url |
https://www.mdpi.com/1422-0067/21/16/5845 |
work_keys_str_mv |
AT augustobleve lipidmetabolismandcancerimmunotherapyimmunosuppressivemyeloidcellsatthecrossroad AT barbaradurante lipidmetabolismandcancerimmunotherapyimmunosuppressivemyeloidcellsatthecrossroad AT antoniosica lipidmetabolismandcancerimmunotherapyimmunosuppressivemyeloidcellsatthecrossroad AT francescamariaconsonni lipidmetabolismandcancerimmunotherapyimmunosuppressivemyeloidcellsatthecrossroad |
_version_ |
1724550401913520128 |